Understanding the reasons behind the low utilisation of thrombolysis in stroke.

Publisher:
Australia
Publication Type:
Journal Article
Citation:
Australasian Medical Journal, 2013, 6 (3), pp. 152 - 167
Issue Date:
2013-01
Full metadata record
Files in This Item:
Filename Description Size
Thumbnail2013004008OK.pdf864.67 kB
Adobe PDF
Background Thrombolysis remains the only approved therapy for acute ischaemic stroke (AIS); however, its utilisation is reported to be low. Aims This study aimed to determine the reasons for the low utilisation of thrombolysis in clinical practice. Method Five metropolitan hospitals comprising two tertiary referral centres and three district hospitals conducted a retrospective, cross-sectional study. Researchers identified patients discharged with a principal diagnosis of AIS over a 12-month time period (July 2009July 2010), and reviewed the medical record of systematically chosen samples.
Please use this identifier to cite or link to this item: